Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. is listed on Nasdaq (REGN) in the Healthcare sector. Prices from Yahoo Finance with their delay; analysis computed from daily price history.
All stocks — US stocks · Heatmap
- Exchange
- Nasdaq · Closed Opens in 22h 01m
- Data delay
- 15 min
- Day range
- 887.22 – 911.57
- Prev. close
- 902.90
Key statistics
- Open
- 887.22
- Previous close
- 902.90
- 52-week range
- 591.52 – 991.73
- Volume
- 1.1M
- Avg volume (3M)
- 780.4K
- Market cap
- 93.6B USD
- P/E (TTM)
- 20.0
- EPS (TTM)
- 45.24
- Dividend yield
- 0.42%
- Sector
- Healthcare Biotechnology
- Listed in
- Nasdaq-100 · S&P 500
- Currency
- USD
Chart
Movement expectation (statistical)
Ranges the price would stay in with a given probability if its recent volatility continues.
| Horizon | ≈68% range (±1σ) | ≈95% range (±2σ) | Past fit |
|---|---|---|---|
| Next trading day | 882.33 – 926.92 ±2.50% | 860.85 – 950.04 | 80% / 98% of the last 250 periods stayed inside |
| Next 5 trading days | 855.86 – 955.59 ±5.67% | 809.97 – 1,009.73 | 78% / 96% of the last 251 periods stayed inside |
ATR range (Next trading day): 873.05 – 935.65 · (Next 5 trading days): 834.37 – 974.33
Daily volatility (σ, 60 days): 2.46%. Basis: close of 2026-11-06 and current price.
⚠️ These are statistical ranges calculated from the stock's own past volatility. They are not a price target, a forecast or a recommendation to buy or sell. Prices can and do move outside them, especially around earnings and news.
Trend reading
Uptrend A description of the indicators, not a recommendation.
- Price is above its 200-day average: the long-term trend is up.
- The 50-day average is above the 200-day (golden-cross structure).
- Short term: above both the 20- and 50-day averages.
- RSI 63.1: neutral zone (30–70).
- MACD is above its signal line (positive momentum).
- 8.8% below the 52-week high.
Pivot points
| Classic | Fibonacci | |
|---|---|---|
| R3 | 939.58 | 925.61 |
| R2 | 925.61 | 916.21 |
| R1 | 914.98 | 910.41 |
| P | 901.01 | 901.01 |
| S1 | 890.38 | 891.61 |
| S2 | 876.41 | 885.81 |
| S3 | 865.78 | 876.41 |
From the 2026-11-06 daily bar (H 911.64 · L 887.04 · C 904.35)
Moving averages
| Moving averages | Price | MA signal |
|---|---|---|
| SMA20 | 844.92 | Above |
| SMA50 | 806.59 | Above |
| SMA200 | 743.09 | Above |
| EMA20 | 859.82 | Above |
| EMA50 | 815.32 | Above |
MA signal: Strong buy · RSI (14): 63.1 · 1M volatility (ann.): 53.2%
Performance
MACD (12, 26, 9)
- MACD
- 38.622
- Signal
- 31.210
- Histogram
- 7.412
- ATR (14)
- 31.30
Position in the sector heatmap
Today #30 of 61 Healthcare stocks in US by change; sector average -0.05%.
Sector peers
Largest Healthcare stocks in US by market cap
| Eli Lilly and CompanyLLY | 1,354.00 USD | -0.79% | 3.6M | 1.21T USD | Healthcare |
|---|---|---|---|---|---|
| Johnson & JohnsonJNJ | 276.22 USD | +1.43% | 8.9M | 664.9B USD | Healthcare |
| AbbVie Inc.ABBV | 291.31 USD | +1.07% | 5M | 514.9B USD | Healthcare |
| Merck & Co., Inc.MRK | 146.73 USD | -0.14% | 7.5M | 361.7B USD | Healthcare |
| UnitedHealth Group IncorporatedUNH | 394.15 USD | -0.40% | 5.8M | 353.2B USD | Healthcare |
| Thermo Fisher Scientific Inc.TMO | 694.76 USD | +2.63% | 2.1M | 257.4B USD | Healthcare |
| Amgen Inc.AMGN | 460.42 USD | +0.03% | 2.6M | 249B USD | Healthcare |
| Gilead Sciences, Inc.GILD | 166.89 USD | -0.41% | 5.7M | 207B USD | Healthcare |
| Abbott LaboratoriesABT | 109.93 USD | -3.23% | 8.2M | 190.4B USD | Healthcare |
| Pfizer Inc.PFE | 29.39 USD | -0.20% | 48.2M | 167.5B USD | Healthcare |
| Danaher CorporationDHR | 230.25 USD | +1.73% | 3.7M | 162B USD | Healthcare |
| Intuitive Surgical, Inc.ISRG | 452.80 USD | -3.36% | 2.1M | 157B USD | Healthcare |
| Regeneron Pharmaceuticals, Inc.REGN | 904.35 USD | +0.16% | 1.1M | 93.6B USD | Healthcare |
Delays: NYSE 20 min · Nasdaq 15 min